Cedars-Sinai Medical Center

Running trials

• Not yet recruiting

  Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)

  NCT07216859· Kaiser Permanente· Source

• Recruiting

  Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

  NCT07388524· Phase 3· National Cancer Institute (NCI)· Source

• Not yet recruiting

  Self-directed Mobile Mindfulness to Address ICU Survivors' Psychological Distress

  NCT07634419· Duke University· Source

• Not yet recruiting

  Trial of First-line Gemcitabine and Nab-paclitaxel With or Without L-glutamine in Advanced Pancreatic Cancer

  NCT07864571· Phase 2· Jun Gong, MD· Source

• Not yet recruiting

  Study of Allogeneic Stem Cell Transplant in Myelodysplastic Syndrome Following Conditioning With Fludarabine and Total Body Irradiation 800 cGy

  NCT07896928· Phase 2· Ronald Paquette· Source

• Not yet recruiting

  PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Multisite)

  NCT07916883· Washington University School of Medicine· Source

• Not yet recruiting

  ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease

  NCT07850063· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  Digital Inhaler Use in Obstructive Lung Disease Care

  NCT07214337· Cedars-Sinai Medical Center· Source

• Enrolling by invitation

  Partial Enteral Nutrition as Therapeutic Augmentation of Advanced Pharmacological Therapy in Patients With Active Crohn's Disease

  NCT07356232· James Lewis· Source

• Recruiting

  Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

  NCT07665372· Johns Hopkins University· Source

• Not yet recruiting

  S-Adenosylmethionine (SAMe) for Chemoprevention of Colorectal Adenomas

  NCT07582003· Phase 1· Jun Gong, MD· Source

• Not yet recruiting

  A Nutritional and Pharmacological Intervention for Body, Brain, and Longevity Effects (NIBBLE)

  NCT06682767· Phase 1/2· Cedars-Sinai Medical Center· Source

• Not yet recruiting

  Barber and Pharmacist Coordination to Improve Blood Pressure Management

  NCT07858695· Cedars-Sinai Medical Center· Source

• Recruiting

  A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.

  NCT07559175· Phase 2· Aimmune Nestlé Health Science US R&D, LLC· Source

• Not yet recruiting

  Cilostazol for Prevention of Recurrent Stroke Trial

  NCT07174414· Phase 3· Stanford University· Source

• Not yet recruiting

  Online Pain Education for Crohn's Disease and Ulcerative Colitis

  NCT07671313· Cedars-Sinai Medical Center· Source

• Recruiting

  A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

  NCT07701941· Phase 1/2· Daiichi Sankyo· Source

• Not yet recruiting

  Pilot Study of Endoscopic Sleeve Gastroplasty for Obese Patients With Heart Failure and Preserved Ejection Fraction

  NCT07798219· Cedars-Sinai Medical Center· Source

• Not yet recruiting

  Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer

  NCT07552181· Phase 2· Yuan Yuan· Source

• Recruiting

  An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

  NCT06996652· Phase 2· Yale University· Source

• Recruiting

  Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation

  NCT07034443· Cedars-Sinai Medical Center· Source

• Recruiting

  Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin

  NCT07441681· Phase 3· NRG Oncology· Source

• Recruiting

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

  NCT07659795· Phase 2· Verastem, Inc.· Source

• Recruiting

  TAVR vs SAVR in Severe Bicuspid Aortic Stenosis

  NCT07413965· Cedars-Sinai Medical Center· Source

• Recruiting

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

  NCT07659782· Phase 2· Verastem, Inc.· Source

• Recruiting

  High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

  NCT07223385· Phase 2· Cedars-Sinai Medical Center· Source

• Recruiting

  A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

  NCT07466316· Phase 3· Children's Oncology Group· Source

• Recruiting

  Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study

  NCT07324031· AtaCor Medical, Inc.· Source

• Not yet recruiting

  Debriefing Consult for Psychiatric Symptoms After Severe Maternal Morbidity

  NCT07684521· Cedars-Sinai Medical Center· Source

• Recruiting

  A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

  NCT05521698· Phase 1· University of Wisconsin, Madison· Source

• Recruiting

  A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)

  NCT07606274· Phase 1/2· Nuevocor Pte. Ltd.· Source

• Recruiting

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  NCT07644559· Phase 2· Verastem, Inc.· Source

• Recruiting

  A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

  NCT07309445· Janssen Research & Development, LLC· Source

• Not yet recruiting

  VR Therapies for IBD

  NCT07590518· Brennan Spiegel· Source

• Not yet recruiting

  ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation

  NCT07015853· Phase 2· Stephen Shiao· Source

• Recruiting

  CHOICE to AVOID or RESIST

  NCT06521021· Cedars-Sinai Medical Center· Source

• Recruiting

  Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  NCT07326566· Phase 2· Black Diamond Therapeutics, Inc.· Source

• Recruiting

  Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

  NCT07321652· Phase 3· Alliance for Clinical Trials in Oncology· Source

• Recruiting

  Applause Study I - Append System Early Feasibility Study

  NCT07278869· Append Medical Ltd.· Source

• Recruiting

  A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

  NCT07458347· Phase 1· Kestrel Therapeutics, Inc.· Source

• Recruiting

  Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

  NCT07298473· Medtronic Cardiac Ablation Solutions· Source

• Recruiting

  Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

  NCT07297979· Phase 1· Amgen· Source

• Not yet recruiting

  Precise Cooler for Donor Heart Transport

  NCT07354763· Cedars-Sinai Medical Center· Source

• Recruiting

  Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  NCT07200830· Phase 3· Alliance for Clinical Trials in Oncology· Source

• Enrolling by invitation

  Neuronal Mechanisms of Learning and Utilizing Abstract Representations

  NCT07454785· Cedars-Sinai Medical Center· Source

• Recruiting

  Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease

  NCT07428447· CND Life Sciences· Source

• Recruiting

  A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

  NCT07409272· Phase 3· Astellas Pharma Global Development, Inc.· Source

• Recruiting

  Efficacy of Rifaximin With NAC in IBS-D

  NCT06727422· Phase 2· Mark Pimentel, MD· Source

• Recruiting

  A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  NCT06968845· Phase 2· Rein Therapeutics· Source

• Recruiting

  Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  NCT07198074· Phase 3· National Cancer Institute (NCI)· Source

Showing 50 of 436.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers23 recruiting
• Lung cancer21 recruiting
• Pancreatic cancer16 recruiting
• Colorectal cancer14 recruiting
• Heart failure13 recruiting
• Prostate cancer13 recruiting
• Bladder cancer10 recruiting
• Kidney cancer10 recruiting
• Stroke10 recruiting
• Crohn's disease9 recruiting
• Coronary artery disease8 recruiting
• Obesity8 recruiting
• Ovarian cancer8 recruiting
• Sarcoma8 recruiting
• Triple-negative breast cancer8 recruiting
• Amyloidosis7 recruiting
• Atrial fibrillation7 recruiting
• Diffuse large B-cell lymphoma7 recruiting
• Endometrial cancer7 recruiting
• Glioblastoma7 recruiting
• Acute myeloid leukaemia6 recruiting
• Gastric and oesophageal cancer6 recruiting
• Neuroendocrine tumours6 recruiting
• Aortic stenosis5 recruiting
• Head and neck cancer5 recruiting
• Liver and biliary tract cancer5 recruiting
• Multiple myeloma5 recruiting
• Ulcerative colitis5 recruiting
• Epilepsy4 recruiting
• Follicular lymphoma4 recruiting
• High blood pressure4 recruiting
• Metastatic breast cancer4 recruiting
• Parkinson disease4 recruiting
• Acute lymphoblastic leukaemia3 recruiting
• Aortic aneurysm3 recruiting
• Chronic kidney disease3 recruiting
• Melanoma3 recruiting
• Myelodysplastic syndromes3 recruiting
• Myeloproliferative neoplasms3 recruiting
• Peripheral artery disease3 recruiting
• Ventricular tachycardia3 recruiting
• Cervical cancer2 recruiting
• Charcot-Marie-Tooth disease2 recruiting
• Chronic lymphocytic leukaemia2 recruiting
• Down syndrome2 recruiting
• Fatty liver disease (MASLD/MASH)2 recruiting
• Hypertrophic cardiomyopathy2 recruiting
• Liver cirrhosis2 recruiting
• Mantle cell lymphoma2 recruiting
• Multiple sclerosis2 recruiting
• Neuroblastoma2 recruiting
• Thyroid cancer2 recruiting
• Type 1 diabetes2 recruiting
• Alzheimer disease1 recruiting
• Congenital heart disease1 recruiting
• Cystic fibrosis1 recruiting
• Depression1 recruiting
• Dilated cardiomyopathy1 recruiting
• Essential tremor1 recruiting
• Hepatitis C1 recruiting
• HIV1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• IgA nephropathy1 recruiting
• Irritable bowel syndrome1 recruiting
• Meningioma1 recruiting
• Myocarditis1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting
• Osteoarthritis1 recruiting
• Pulmonary arterial hypertension1 recruiting
• Rheumatoid arthritis1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting
• Vascular dementia1 recruiting

Closed trials

• Withdrawn

  Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma

  NCT05341947· Phase 1· Jeremy Rudnick, M.D· Source

• Completed

  RCT of VR Therapy for IBS

  NCT06687616· Christopher Almario· Source

• Withdrawn

  Efficacy of Virtual Reality (VR) for Irritable Bowel Syndrome

  NCT06257472· Anthony Lembo· Source

• Terminated

  ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

  NCT06418711· Phase 3· Mannkind Corporation· Source

• Completed

  VOLT-AF IDE Clinical Study

  NCT06223789· Abbott Medical Devices· Source

• Completed

  The PROTEMBO Trial

  NCT05873816· Protembis GmbH· Source

• Completed

  RECOVER-AUTONOMIC Platform Protocol

  NCT06305780· Phase 2· Kanecia Obie Zimmerman· Source

• Completed

  Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors

  NCT06169124· Phase 2· National Cancer Institute (NCI)· Source

• Completed

  Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

  NCT06247735· Phase 2· Kowa Research Institute, Inc.· Source

• Completed

  SafeHeal Diverting Ileostomy Pivotal Study

  NCT06152276· SafeHeal Inc· Source

• Completed

  Using Mirabegron to Increase BP in Patients With POTS

  NCT06133075· Phase 2· Cedars-Sinai Medical Center· Source

• Withdrawn

  A Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate Cancer

  NCT05567679· Early phase 1· Edwin Posadas, MD· Source

• Terminated

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· Phase 2· Pliant Therapeutics, Inc.· Source

• Completed

  Impact of Protect Your Colon™ on CRC Screening

  NCT05929820· Cedars-Sinai Medical Center· Source

• Recruiting

  A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

  NCT06016842· Phase 3· Ipsen· Source

• Completed

  Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantation for Multiple Myeloma

  NCT05961215· Cedars-Sinai Medical Center· Source

• Completed

  Elemental Diet and Gut Microbiome

  NCT05978973· Cedars-Sinai Medical Center· Source

• Completed

  RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

  NCT05595369· Phase 2· Kanecia Obie Zimmerman· Source

• Completed

  A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients

  NCT05954988· Phase 1· Rein Therapeutics· Source

• Completed

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM

  NCT05767346· Phase 3· Cytokinetics· Source

• Recruiting

  A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  NCT05442567· Phase 3· Takeda· Source

• Completed

  A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF

  NCT04907825· Phase 4· Cedars-Sinai Medical Center· Source

• Completed

  A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen

  NCT05769608· Phase 2· Mineralys Therapeutics Inc.· Source

• Terminated

  A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

  NCT05590377· Phase 1/2· Teva Branded Pharmaceutical Products R&D LLC· Source

• Completed

  A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1)

  NCT05694260· Phase 2· Esperion Therapeutics, Inc.· Source

• Completed

  A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)

  NCT05829226· Phase 1· PureTech· Source

• Completed

  Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer

  NCT05086250· Early phase 1· Cedars-Sinai Medical Center· Source

• Completed

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· Phase 3· Boehringer Ingelheim· Source

• Completed

  A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.

  NCT05924243· Phase 1· Hoffmann-La Roche· Source

• Terminated

  STEM-PD Open Label Extension (OLE)

  NCT04799418· Scion NeuroStim· Source

• Withdrawn

  177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma)

  NCT04315246· Phase 1/2· Y-mAbs Therapeutics· Source

• Terminated

  Pilot Study of Posaconazole in Crohn's Disease

  NCT04966585· Phase 4· Cedars-Sinai Medical Center· Source

• Completed

  A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis

  NCT05442047· Phase 2· Novo Nordisk A/S· Source

• Withdrawn

  Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer

  NCT03872505· Phase 2· Cedars-Sinai Medical Center· Source

• Completed

  A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

  NCT05360680· Phase 1· Cue Biopharma· Source

• Completed

  STEM-Parkinson's Disease

  NCT04797611· Scion NeuroStim· Source

• Completed

  Behavioral Economics to Improve Antihypertensive Therapy Adherence

  NCT04029883· Cedars-Sinai Medical Center· Source

• Terminated

  (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

  NCT05241873· Phase 1· Blueprint Medicines Corporation· Source

• Completed

  A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors

  NCT05082610· Phase 1· Hummingbird Bioscience· Source

• Completed

  A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

  NCT05014672· Phase 2· Calliditas Therapeutics Suisse SA· Source

• Recruiting

  A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

  NCT04779320· Phase 3· Takeda· Source

• Terminated

  SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study

  NCT05010850· SafeHeal Inc· Source

• Completed

  Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators

  NCT04722341· Cedars-Sinai Medical Center· Source

• Completed

  A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

  NCT04945460· Phase 2· Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA· Source

• Completed

  Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System

  NCT05007925· Shockwave Medical, Inc.· Source

• Completed

  Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation

  NCT05130268· Phase 4· American Heart Association· Source

• Completed

  Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

  NCT05172024· NYU Langone Health· Source

• Terminated

  MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

  NCT05090566· Phase 2· Pfizer· Source

• Completed

  Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

  NCT04743310· Phase 2· John Yu· Source

• Terminated

  KZR-261 in Subjects With Advanced Solid Malignancies

  NCT05047536· Phase 1· Kezar Life Sciences, Inc.· Source

Showing 50 of 166.

Conditions

Diseases this institution publishes on or runs trials for.

• Heart failure177 works · 24 trials
• Stroke150 works · 16 trials
• Prostate cancer127 works · 35 trials
• Obesity110 works · 10 trials
• Coronary artery disease93 works · 15 trials
• Colorectal cancer85 works · 39 trials
• Liver and biliary tract cancer69 works · 23 trials
• Atrial fibrillation56 works · 14 trials
• Aortic stenosis48 works · 17 trials
• Crohn's disease41 works · 17 trials
• Pancreatic cancer41 works · 41 trials
• Bladder cancer40 works · 25 trials
• Ulcerative colitis39 works · 12 trials
• Sarcoma34 works · 26 trials
• Triple-negative breast cancer31 works · 20 trials
• Fatty liver disease (MASLD/MASH)29 works · 7 trials
• Multiple myeloma23 works · 15 trials
• Metastatic breast cancer16 works · 10 trials
• Neuroendocrine tumours16 works · 11 trials
• Hypertrophic cardiomyopathy16 works · 4 trials
• Amyloidosis15 works · 11 trials
• Idiopathic pulmonary fibrosis15 works · 6 trials
• Endometriosis14 works · 0 trials
• ALS (motor neurone disease)13 works · 4 trials
• Ventricular tachycardia13 works · 5 trials
• Congenital heart disease13 works · 4 trials
• Pulmonary arterial hypertension13 works · 4 trials
• Sarcoidosis10 works · 0 trials
• Irritable bowel syndrome10 works · 4 trials
• Hodgkin lymphoma10 works · 2 trials